Improving Access to Care for Patients with Psoriasis and Psoriatic Arthritis: The Impact of the Temporary Reciprocity to Ensure Access to Treatment Act and Remote Care Policy Reform
Restricted accessArticle commentaryFirst published online April, 2022
Improving Access to Care for Patients with Psoriasis and Psoriatic Arthritis: The Impact of the Temporary Reciprocity to Ensure Access to Treatment Act and Remote Care Policy Reform
ArmstrongAWKoningJWRowseSTanHMamoloCKaurM. Under-Treatment of patients with moderate to severe psoriasis in the United States: Analysis of medication usage with health plan data. Dermatol Ther (Heidelb). 2017;7(1):97-109. doi:10.1007/s13555-016-0153-2.
2.
BattafaranoDFDitmyerMBolsterMB, et al.2015American college of rheumatology workforce study: Supply and demand projections of adult rheumatology workforce, 2015-2030. Arthritis Care Res (Hoboken). 2018;70(4):617-626. doi:10.1002/acr.23518.
3.
SchmajukGTonnerCYazdanyJ. Factors associated with access to rheumatologists for Medicare patients. Semin Arthritis Rheum. 2016;45(4):511-518. doi:10.1016/j.semarthrit.2015.07.007.
4.
HaroonMGallagherPFitzGeraldO. Diagnostic delay of more than 6monthscontributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045-1050. doi:10.1136/annrheumdis-2013-204858.
